Citi Maintains Buy Rating on AstraZeneca
Citi analyst Graham Parry has reaffirmed a buy rating for AstraZeneca, reflecting continued confidence in the company's outlook.
Stocks · News reference
AstraZeneca Canada and Breast Cancer Canada Announce Research Funding
AstraZeneca Canada and Breast Cancer Canada are investing $200,000 in matched research funding to support initiatives addressing breast cancer survivorship.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
AstraZeneca Launches 'Meet Your Mark' Campaign to Promote Cancer Biomarker Testing
AstraZeneca has introduced a new public health campaign featuring actor Mark-Paul Gosselaar to encourage patients to discuss biomarker testing as a standard part of cancer care.
AstraZeneca Enters Research Collaboration with Tremont AI
AstraZeneca has partnered with Tremont AI to develop and evaluate artificial intelligence models for preclinical safety assessment.